REGEN BIOPHARMA, INC. Additional Paid in Capital
REGEN BIOPHARMA, INC. (RGBP) had Additional Paid in Capital of $16.52 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-17
- 2026-06-30: Additional Paid in Capital $16.52M.
- 2026-03-31: Additional Paid in Capital $16.48M.
- 2025-12-31: Additional Paid in Capital $16.30M.
- 2025-09-30: Additional Paid in Capital $15.63M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $16.52M 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $16.48M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $16.30M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $15.63M 10-Q · filed 2026-08-17 | |
| 2025-06-30 | $15.50M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $15.46M 10-Q · filed 2025-05-28 | |
| 2024-12-31 | $15.46M 10-Q · filed 2025-05-16 | |
| 2024-09-30 | $15.40M 10-K · filed 2025-12-30 | $14.68M 8-K · filed 2024-11-29 |
| 2024-06-30 | $14.46M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $14.31M 10-Q · filed 2024-04-24 | |
| 2023-12-31 | $14.12M 10-Q · filed 2024-01-19 | |
| 2023-09-30 | $14.64M 10-K · filed 2025-05-13 | $13.91M 10-K · filed 2023-11-20 |
| 2023-06-30 | $13.66M 10-Q · filed 2023-07-25 | |
| 2023-03-31 | $13.66M 10-Q · filed 2023-04-18 | |
| 2022-12-31 | $13.08M 10-Q · filed 2023-01-19 | |
| 2022-09-30 | $11.58M 10-K · filed 2023-11-20 | |
| 2022-06-30 | $11.20M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $9.79M 10-Q · filed 2022-04-21 | |
| 2021-12-31 | $9.71M 10-Q · filed 2022-01-20 | |
| 2021-09-30 | $8.64M 10-K · filed 2022-11-15 | |
| 2021-06-30 | $8.39M 10-Q/A · filed 2021-12-22 | |
| 2021-03-31 | $8.33M 10-Q · filed 2021-08-18 | |
| 2020-12-31 | $8.33M 10-Q · filed 2021-08-13 | |
| 2020-09-30 | $8.31M 10-Q/A · filed 2021-12-22 | |
| 2020-06-30 | $8.30M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $8.30M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $8.31M 10-Q · filed 2021-08-05 | |
| 2019-09-30 | $8.26M 10-Q · filed 2021-08-05 | |
| 2019-06-30 | $8.24M 10-Q · filed 2019-10-24 | |
| 2019-03-31 | $7.85M 10-Q · filed 2019-08-29 | |
| 2018-12-31 | $7.69M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $7.52M 10-K · filed 2021-06-21 | |
| 2018-06-30 | $7.06M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $6.95M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $6.84M 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $6.64M 10-K · filed 2018-12-27 | |
| 2017-06-30 | $6.59M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $6.52M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $21.71M 10-Q · filed 2017-01-27 | |
| 2016-09-30 | $18.96M 10-Q · filed 2017-01-27 | |
| 2016-06-30 | $16.63M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $14.55M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $13.63M 10-Q · filed 2016-01-28 | |
| 2015-09-30 | $11.66M 10-K · filed 2016-12-21 | |
| 2015-06-30 | $11.21M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $9.91M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $507.52K 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $485.10K 10-Q/A · filed 2017-04-28 | |
| 2014-06-30 | $485.10K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $485.10K 10-Q · filed 2014-05-05 | |
| 2013-09-30 | $185.13K 10-K · filed 2014-12-18 |